Human Tissue Technology Private Limited
About Human Tissue Technology Private Limited
Data last updated:
Human Tissue Technology Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2020PTC117286.
The company has an authorised share capital of ₹4.01 Cr and a paid-up capital of ₹3.77 Cr. It is led by directors Pankaj Narayan Matolia and Aurindam Das Bakshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 142/P 143/P Village Vasana Chacharwadi Taluka Sanand, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.06 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹3.75 Lakh (net margin 46.5%) and EBITDA of ₹3.84 Lakh (EBITDA margin 47.6%). Revenue has grown at a compounded annual rate (CAGR) of 347% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Human Tissue Technology Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered Address142/P 143/P Village Vasana Chacharwadi Taluka Sanand, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Human Tissue Technology Private Limited
FY 2025 filings availableHuman Tissue Technology Private Limited reported revenue of ₹8.06 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 347% over three years, including 48% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.6% | ||||
| Net Profit Margin | 46.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Human Tissue Technology Private Limited, buy the company report.
Board of directors of Human Tissue Technology Private Limited
Human Tissue Technology has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Narayan Matolia | Director | 25 Feb 2022 | 4 Years 8 Months | Current |
| Aurindam Das Bakshi | Additional Director | 10 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Human Tissue Technology Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ebullient Pharmaceuticals Private Limited | ₹8.17 Lakh (FY 2025) | -25.0% | Satara, Maharashtra, India | |||
| Kapynag Pharma Private Limited | ₹8.16 Lakh (FY 2025) | -96.0% | Nashik, Maharashtra, India | |||
| Ellia Cytocare Private Limited | ₹8.12 Lakh (FY 2025) | -51.0% | Chauhan Patti, Delhi, India | |||
| Vijay Shree Chem Drugs Private Limited | ₹8.12 Lakh (FY 2025) | -11.0% | Uttar Pradesh, India | |||
| PRK Pharmanlysts Private Limited | ₹8.07 Lakh (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Human Tissue Technology Private Limitedthis company | ₹8.06 Lakh (FY 2025) | ₹3.75 Lakh | 46.5% | 48.0% | Ahmedabad, Gujarat, India | |
| Wockridge Global Healthcare Private Limited | ₹8.06 Lakh (FY 2025) | -85.0% | Mumbai, Maharashtra, India | |||
| Med-Ortheve Healthcare Private Limited | ₹8.05 Lakh (FY 2023) | Moshi, Maharashtra, India | ||||
| Sangus Life Science Private Limited | ₹8.02 Lakh (FY 2022) | -12.0% | Patna, Bihar, India | |||
| Shakun Pharma Private Limited | ₹8.02 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Midas Care Holdings Pvt Ltd | ₹7.97 Lakh (FY 2017) | -46.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Human Tissue Technology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Human Tissue Technology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Human Tissue Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Human Tissue Technology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Human Tissue Technology Private Limited has 8 board changes on record since 2022: 3 appointments and 5 cessations. The latest: Aurindam Das Bakshi was appointed as Additional Director on 10 Mar 2025.
Frequently asked questions
Human Tissue Technology is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2020 (6+ years old) and is registered under CIN U24100GJ2020PTC117286.
Human Tissue Technology has 2 current directors:
- Pankaj Narayan Matolia - Director
- Aurindam Das Bakshi - Additional Director
The latest financial statements of Human Tissue Technology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Human Tissue Technology is U24100GJ2020PTC117286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Human Tissue Technology was incorporated on 13 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Human Tissue Technology by revenue are Ebullient Pharmaceuticals Private Limited, Kapynag Pharma Private Limited, Ellia Cytocare Private Limited, Vijay Shree Chem Drugs Private Limited, PRK Pharmanlysts Private Limited and 5 more, all in the Pharma industry (Formulations).
Aurindam Das Bakshi was appointed as Additional Director on 10 Mar 2025. Jitendra Kumar Singhal ceased to be Additional Director on 30 Sep 2022. Pankaj Narayan Matolia ceased to be Additional Director on 30 Sep 2022. Human Tissue Technology has 8 board changes on record in total.
The registered office of Human Tissue Technology is at 142P 143P Village Vasana Chacharwadi Taluka Sanand, Ahmedabad, Gujarat, India – 382213.
Human Tissue Technology operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Human Tissue Technology is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Human Tissue Technology can be reached at its registered office: 142P 143P Village Vasana Chacharwadi Taluka Sanand, Ahmedabad, Gujarat, India – 382213.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
